Helmi Sulaiman
@edenhelmi
Followers
958
Following
1,092
Media
1,193
Statuses
5,342
ID physician at the University of Malaya.
University of Malaya
Joined September 2014
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
#FGO
• 448488 Tweets
Félix
• 139257 Tweets
#光る君へ
• 83157 Tweets
エレちゃん
• 79107 Tweets
Carolina Marín
• 70228 Tweets
#Hockey
• 68968 Tweets
エレシュキガル
• 55031 Tweets
NuNew with Aheye
• 54291 Tweets
ビースト
• 52763 Tweets
Lakshya
• 42022 Tweets
#ブラックペアン
• 24862 Tweets
SB19 IS LIMITLESS
• 24360 Tweets
アペンド
• 22012 Tweets
Axelsen
• 18500 Tweets
デスティニー
• 18012 Tweets
Hugo
• 16756 Tweets
サーヴァントコイン
• 14368 Tweets
#だれかtoなかい
• 12733 Tweets
女子バスケ
• 12428 Tweets
ベルギー
• 12148 Tweets
和泉式部
• 11913 Tweets
コマンドー
• 11816 Tweets
Mete Gazoz
• 11697 Tweets
Pinned Tweet
1
10
24
Is anaerobic coverage necessary for aspiration pneumonia with metronidazole or Augmentin?
NEJM JWatch reports from a large retro study with N ~ 4000
Findings show no added mortality benefit but an increased risk of CDI
#IDTwitter
#IDXposts
10
144
368
New drugs against GNB by Ursula Theuretzbacher
#ECCMID2023
In Malaysia, we only have Cefta-avi for resistant GNB infections!
We hope
@SHIONOGI_JP
will include Malaysia in the list of countries for generic cefiderocol- a project by
@gardp_amr
@KKMPutrajaya
@DrZalihaMustafa
4
60
155
Everything Acinetobacter in the second supplement of the May 2023 issue of the
@CIDJournal
, including:
1) Epidemiology and mechanisms of resistance of 🦀
2) Available Rx options for🦀
3) PK/PD of SUL-DUR
4) ATTACK 2 trial (SUL-DUR vs🦀)
#IDtwitter
2
57
145
@MissUSA
@sarahr_summers
"I said something that I now realize can be perceived as not respectful, and I apologize".
Please.. You should instead say;
:I said something that was disrespectful, and I apologize" (period!!!)
Even your apology sounds so phony.
5
6
118
SAFO Trial in
#ECCMID2023
Main findings:
Shorted duration of bacteremia
But similar mortality
As per predicted by
@DrToddLee
QnA:
How many were complicated vs. unc.
The majority were unc.
Sec outcome of persistent bacteremia was defined as bacteremia > 72H
3
56
134
Blood culture remains an imperfect tool for a deadly condition
To improve sepsis dx, PCR-based testing needs to improve on the failings of BCs—e.g., through improved sensitivity and faster time to result— all while maintaining specificity
2
29
115
The 2024 CLSI M100 document is available online now for free
The updates include
Ceftazidime-avibactam & aztreonam synergy test using Broth Disc Elution Method (finally we have a guide for this)
@Dr_ChrisKCLai
@Rasidah
@stevenlimcl
@shaharudeen
@alif82
@adammashraff
3
39
115
Reduced mortality with late dose adjustment of ß-lactams in septic patients with AKI!
A session by
@emilylheil
titled: "Treatment and Antimicrobial Stewardship with New Agents in HAP/VAP"
@fikreeahmad
@ambaras_khan
2
31
112
SAB management updates by IDSA/ESCMID
#ESCMIDGlobal2024
The term “complicated” SAB varies and does not always suggest longer treatment
Solution: low vs. high-risk populations for SAB
2
36
100
Positive IGRA cannot be used to diagnose active TB
But how about negative IGRA:
Can I use it to rule TB out?
Answer: ca. 8–19% of patients can have a negative IGRA result when presenting with active TB
Riding the wave of IGRA discussion on
#IDTwitter
7
31
98
What's the role of pip-tazo, cefepime, cefta-avi, & ceftolozane-tazobactam in ESBL infections?
Eagerly awaiting PETER-PAN completion
Hopefully, MERINO-3 will launch soon to test whether
ceftolozane-tazobactam can be used for ESBL BSI
@padstamundo
#IDTwitter
and
#IDWeek2023
1
38
96
A new review on persistent MSSA bacteremia.
What are our (limited) options to deal with it?
ICYMI
@ABsteward
cc
@laocarinadetapi
5
17
87
A review on the off-label use of novel antibiotics for treating MDR bacterial infections
By Prof Po-Ren Hsueh et al.
0
36
78
A very enlightening talk by Angela Hutner on simple vs complicated UTI definitions
Simplicity wins
Anything that is beyond the bladder = complicated UTI (including prostatitis)
This will be updated in 2024 by both the IDSA and ESCMID
#IDTwitter
#IDXposts
6
31
80
Is Ceftolozane-tazobactam a good option for infections caused by ESBL-producing Enterobacterales?
And will it be tested in a clinical trial against meropenem (e.g. MERINO-3 trial)?
@padstamundo
A great talk by Pranitha Tamma at
#ESCMIDGlobal2024
1
17
77
Thanks
@RahulGarg_89
for letting me know the existence of this good paper
What are some of the recalcitrant myths in ID
1) Avoid Cefazolin in CNS infections
2) Avoid LNZ + SSRI
3) No dose reduction is needed for LNZ in renal insuff.
4) Clinda is the first line Rx for penA pt
4
16
75
"Oral Therapy for Staph. Bacteremia- Routine, In Whom, When, and How Long"
George Sakoulas
The induction phase (IV-lead tx) will influence the success/failure of the consolidation phase (PO step-down) in SAB
#IDWeek2023
1
25
72
What is the clue for amp C (and not ESBL) when CRO-resistant, even for E coli or KP?
Use Cefoxitin AST result
If it is R to it, but S to cefepime/FEP
Likely AmpC
and we may be able to use FEP rather than mero
#IDweek2023
@adammashraff
@fikreeahmad
@SyamhaninA
@SazaliBasri
5
17
62
Polymyxins and carbapenems: their place in the treatment of MDR Gram-negative infection today
#ECCMID2023
This a very relevant talk for us in Southeast Asia (exc Singapore)
@alif82
@SyamhaninA
@fikreeahmad
@shaharudeen
@GSRajahram
@stevenlimcl
@SazaliBasri
@HanzHc
3
27
61
Can we change from IV to oral antibiotics in Gram-neg bacteremia?
A 2023 paper highlighted by
@SinHui91
(our new ID trainee)
Jom baca
@SazaliBasri
@Rasidah
@hiujian23
@GSRajahram
@stevenlimcl
@shaharudeen
@alif82
@adammashraff
@fikreeahmad
3
14
62
Switch to Oral Antibiotics in Gram-negative Bacteremia (SOAB) trial results will be presented on day 1 of
#ECCMID2023
P: Simple GNB BSI and have received IV Abx for 3-5 days
I: Full IV Abx course
C: IV to PO stepdown
O: Rx failure at 90-days
#IDTwitter
2
14
58
Recently approved antibacterial agents in real life
#ECCMID2023
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Alessandro RUSSO, Italy
1
17
58
SUL-DUR for CRAB
DUR is a novel DBO non–β-lactam BLI
It is a highly potent inhibitor of Aciba-derived cephalosporinase and class D β-lactamases, including carbapenemases of the OXA family (OXA-23, OXA-24/40), which are prevalent in CRAB
#IDtwitter
1
14
57
How long should we treat empyema thoracis with antibiotics?
A: 14-21 days
B: 28-42 days
A paper for one of the JC's sessions next year:
@HanzHc
@SazaliBasri
2
17
55
CZA ATM synergy test using disc elution method will be recommended by the CLSI M100 2024
Finally, a guidance for this
@adammashraff
@DrSyamhanin
@davidantibiotic
0
18
55
Oral ampho-B (Encochleated) for Crypto meningitis
-presented during
@IDWeek2022
Trying to use this final week to view and download as many lectures as I can of the 2022 ID Week
And this is a gem!
@alif82
@SazaliBasri
@HanzHc
@shaharudeen
@GSRajahram
@Rasidah
2
27
54
CRO-resistant NTS is usually caused by CMY-AmpC/CTX-M genes
Colonizing Enterobacterales can transfer the plasmids with ESBL/Amp-C to Salmonella - AST needs to be repeated in suspected Rx failure for Salmonellosis
The paper also touches on azithro AST
1
13
52
A new paper from
@jasonroberts_pk
@hfzaziz2
et al.
Antifungal Dosing in Critically Ill Patients on Extracorporeal Membrane Oxygenation
Let's read this
@CRE_RESPOND
@AinJamal9
@SyamhaninA
@adammashraff
@fikreeahmad
0
14
51
The new IDSA guidelines for treating MDR GNB infections are out!
It's incredible how these experts consistently deliver updates every year
Truly impressive!
#IDTwitter
Jom baca
@Rasidah
@shaharudeen
@alif82
@dr_aishah_wahid
@hiujian23
1
17
50
#IDtwitter
#IDXposts
How do U test for Tigecycline MIC for Acineto, given the absence of guidance by CLSI & FDA, esp. since the IDSA does support its use for the infections by it?
NB: Mino is N/A in our hosp
@wwrighID
@dralicehan
@JGPharmD
@EB_Hirsch
@IdVilchez
@adil_rashidk
1
17
49
Interesting talk by Dr. Yahav on the treatment of carbapenem-resistant GNB infections
#ADVANCEID
0
5
48
Could this be an unintended consequence of MERINO trial, where physicians "downgrade" other commonly used antibiotics in terms of efficacy even for non-severe ESBL/ ceftriaxone resistant Enterobacterales infections like UTI?
#IDTwitter
2
11
44
Have U treated Melioidosis cases with persistent bacteremia leading to poor outcomes despite appropriate Tx?
If yes, BlaOXA could be the reason
A local paper:
H/T:
@ADVANCE__ID
seminar series
@GSRajahram
@stevenlimcl
@Rasidah
@alif82
@shaharudeen
4
9
44
Which of these is important when it comes to blood culture?
1) Blood culture volume
OR
2) Transport time of the bottles to the lab
This was presented at the
@ECCMID2023
sharing session during the
@ADVANCE__ID
meeting
3
11
44
A talk by
@InfectiousMoYin
at
#ESCMIDGlobal2024
Issues related to observational studies in deciding whether we should perform a follow up blood culture in GNB bacteremia
2
12
43
Myth: Bactericidal Agents Are Necessary for the Treatment of BSI at
#idweek2022
A nice and easy-to-follow account of bactericidal vs. bacteriostatic agents and activity
@SyamhaninA
@fikreeahmad
@adammashraff
@shaharudeen
@andrewchangID
@Rasidah
@suraya_sudenia
@cllau888
3
19
43
We are so blessed to have the Twitter celebrity Dr
@ummuafeera
delivering talks on supplement (methanamine hippurate) for uncomplicated UTI
She has researched its availability at Lazada or Shopee
Unfortunately, not yet!
#AM9
@ProfAdeeba
@SazaliBasri
@oneliyana
@eeyorezee
4
7
42
Great talk by
@davidantibiotic
on CRE and CRPA Tx during
#AMRsymposium2023
He touched on the synergy test for CZA ATM using BDE method
And COMBINE data for CZA ATM
@GSRajahram
@stevenlimcl
@SazaliBasri
@HanzHc
@DrSyamhanin
2
13
40
CRAB Tx using agents that we have locally
We might do more harm if we add meropenem/imi to amp-sulbactam Tx for CRAB
And if we use mino, use it when its MIC is 1mg/L or lower to attain the PKPD target
A talk by
@emilylheil
#IDWeek2023
1
13
40
SAFO trial preliminary data will be presented on day 1 of
#ECCMID2023
Cloxa alone vs. Cloxa + IV fosfomycin for MSSA bacteremia
Dosing regimens:
Cloxa 2g Q4H
Fosfomycin 3g Q6H
I wonder what the results will be
#IDTwitter
3
12
40
Interesting talk:
Avibactam is effected more readily by augmented renal clearance compared to ceftazidime, so much so that the serum concentrations fall below 4 mg/L and the ratio of 1:4 (CAZ: avi) is increased with ARC, compromising its BLI activity
#ESCMIDGlobal2024
2
12
40
Should we treat uncomplicated CRE BSI for
A) 7,
B) 10, or
c) 14 days?
#IDtwitter
A new paper highlighted by Dr. Julia, a M'sia's ID fellow
Jom baca
@SazaliBasri
(opps, corrected)
@adammashraff
@fikreeahmad
@GSRajahram
@Rasidah
@alif82
3
17
40
Compassionate use of Cefepime-zidebactam in XDR P. aeruginosa infection
When combined with FEP that targets PBP3, zidebactam synergistically enhances the bactericidal activity of FEP, thus functioning as a “β-lactam-enhancer”
It also attacks PBP2
0
11
39
An excellent lecture on beta-lactam TDM presented during "The 3rd Annual Worldwide Precision Dosing Seminar" by
@erin_barreto
#IDTwitter
#PKPD
Session 1 is ending soon
But you can still register for Session 2
@AinJamal9
@CRE_RESPOND
@hfzaziz2
2
10
35
A new publication in IJAA looking at 21 antibiotic guidelines for CRGNB, including CRE, CRPA, and CRAB
@InfectiousMoYin
@davidantibiotic
@JGPharmD
@KanjSouha
@abimaneshID
@SyamhaninA
@adammashraff
1
11
37
Is it safe to use cefazolin in MSSA bacteremia?
A meta analysis of 14 studies published in CMI by
@ASPphysician
et. al.
@ABsteward
@khalideljaaly
@nicolencz
@suraya_sudenia
@SyamhaninA
1
30
38
Which Trizole that should be TDM-ed?
When should the sampling be performed and what are the target levels?
Utility of Triazole Antifungal TDM - Insights from the
@SIDPharm
by
@ErinMcCreary
et al.
DM me if you want the paper
:-)
4
7
37
Classification for B-Lactamases by Dr. K Bush
She talked about the hx of Bla enzymes and their classification, inc the Bush and the Ambler classifications
@adammashraff
@SazaliBasri
@HanzHc
@eeyorezee
@fikreeahmad
@shaharudeen
@Rasidah
Tx
@ABsteward
2
10
36
Can we use Ceftriaxone to treat Serratia infections when tested S in vitro?
Super 🆕️🔥article
✨️Described fundamental differences in the propensity for E.cloacae & S.marcescens toward AmpC de-repression & induction
✨️Explains why E.cloacae has an increased propensity toward development of ceftriaxone resistance vs Serratia
1
48
141
11
5
35
COMBACTE CDI conclusion slide:
Metro should not be used in CDI
and our treatment strategy should be based on the risk of CDI recurrence than its severity
#ESCMIDGlobal2024
2
11
35
Efficacy of cefiderocol- vs. colistin-containing regimen for the Rx of bacteremic VAP caused by CRAB
#ECCMID2023
Almost everyone (98%) treated with colistin died on day-30 !
@SyamhaninA
@adammashraff
@alif82
@SazaliBasri
@HanzHc
@GSRajahram
@Rasidah
@fikreeahmad
4
9
33
Recently approved antibacterial agents in real life
#ECCMID2023
Fosfomycin for non-urinary tract infections: a systematic review
Shreya Das ADHIKARI, India
@alif82
@SyamhaninA
Time to consider bringing in IV Fosfomycin locally
1
10
33
Oral step down for IE: yay or nay?
A new paper highlight on POET trial after 6 years of F/U - the results are encouraging
Oral is the new IV
#IDTwitter
@BradSpellberg
Jom baca
@Rasidah
@angpp2209
@GSRajahram
@SazaliBasri
@stevenlimcl
@HanzHc
3
6
33
The best stat workshop I've ever attended
It was intense but we learned so much within a short period of time- if you have an opportunity to attend the Cochrane Taiwan workshop, you should grab it!
1
5
32
One of the slides of the lectures by Michael Satlin
Would you use Cefepime or Meropenem in this case?
@adammashraff
@fikreeahmad
@SyamhaninA
@SazaliBasri
@shaharudeen
@alif82
#IDWeek2023
7
13
33
Just published!
Hats off to the team led by
@DrEmilyMcD
and
@DrToddLee
Very clear and concise
Remember to check the supplementary tables!
Let's read this
@alif82
@shaharudeen
@SyamhaninA
@fikreeahmad
@PuiLi_Wong
@SazaliBasri
@eeyorezee
2
4
33
Can we switch IV to PO Abx for uncomplicated Enterobacterales BSI after 3-5 days of IV Tx?
N < sample size due to Covid-19
65% of the PO arm used oral ß-lactams
The duration was a bit long: 11 (IV) vs. 14 (PO) days
Similar 1/2ndry outcomes for both arms
2
9
32
A fascinating talk by
@jhorcajada
An initiative under the ADVANCE ID network by
@davidantibiotic
et. al.
@SyamhaninA
@cllau888
@Rasidah
@fikreeahmad
@adammashraff
@stevenlimcl
@andrewchangID
@angpp2209
1
11
31
Important questions that are addressed by ESCMID and IDSA for MRSAB management
#ESCMIDGlobal2024
A talk by Mica Paul
2
1
32
Thank you
@gardp_amr
, for listening to our struggle with access to new antibiotics
Here, we shared a story related to IV Cefiderocol
Hopefully, through collaboration with
@ADVANCE__ID
and
@gardp_amr
, we can have better access to these new drugs
0
9
31
Global Differences in the Management of SAB:
No International Standard of Care
Let's read this paper:
@shaharudeen
@alif82
@SazaliBasri
@HanzHc
@PuiLi_Wong
@ummuafeera
@GSRajahram
@andrewchangID
@Rasidah
1
8
30
Strep. bovis and Enterococcus BSI are not the only bacteremia associated with colorectal cancer
N = 83 754 (of these, 1030 had CRC)
The organisms are 👇
@SazaliBasri
@HanzHc
Publication from Queensland by
@davidantibiotic
@padstamundo
et al.
1
12
31
Colistin Vs Cefiderocol-based Rx for CRAB VAP
Retrospec
Single center
Small N
Col = 54
CFDC = 19
Mortality data is damning for Col:
14-day: 75.9% Vs 5.2% (CFDC)
30-day mortality: 98.1% Vs 31.5%
@SyamhaninA
@SazaliBasri
@adammashraff
@fikreeahmad
@alif82
@GSRajahram
@Rasidah
🆕️⚡️⚡️🟢
#IJAA
The largest study evaluating the clinical outcome for patients with bacteremic VAP caused by CRAB treated with cefiderocol or colistin-based regimens in COVID-19 patients in the ICU
#IDTwitter
The study was presented at
#ECCMID2023
4
30
82
0
13
31
Get ready to vibe with the coolest minds in the game at the AMR Symposium 2023! 🚀🌟
@unimalaya
@MonashMalaysia
@NUSingapore
#AMR2023
#SaveOurAntibiotics
💊
Date: 4 & 5 Dec 2023
Venue: Connexion Conference, Nexus, Bangsar
Registration link:
1
13
29
Join the
@ADVANCE__ID
ESCMID Global updates on
15 May (Wed) at 6:00pm Singapore/MY time / 8:00pm Brisbane time
I'll share the SAB guideline updates, and others will speak on novel antibiotics, GNB & late-breaking trials, as well as TDM
#IDtwitter
Link:
2
11
30
A great talk by Ryan Shield highlighting on resistance development with Cefta-avi vs. Ceftolozane-taz for the treatment of BSI/PNA by PA
The prospective study showed that CZA use led to higher rates of R development!
#ESCMIDGlobal2024
2
1
29
Join our 2023 Antibiotic Masterclass!
Date: 4/02/2023
Time: 8 am - 5 pm
Venue: Connexxion Conference Centre
Theme: Challenging ID cases in my daily practice
Our panel of experts & speakers includes
@syctong
and
@davidlye70
To register
Book your seat!
1
17
29
A timely publication: we are reviewing our hospital antibiotic guidelines and tomorrow is the respi section day
@SazaliBasri
@HanzHc
1
6
28
Ceftazidime for GPC?
Yay or nay
“Additionally, one study assessed antimicrobial activity of nearly 200 clinical Streptococci isolates and found ceftazidime to have the least amount of activity - even worse than vancomycin, ceftriaxone, cefepime, penicillin, and erythromycin”
Looking to Cover Confidently? Check out this week’s KASIC pearl to Know your Antibiotic: Ceftazidime’s Coverage Conundrum
#IDtwitter
#AntimicrobialResistance
#antimicrobialstewardship
3
15
35
3
5
27
E. coli from blood culture with the following AST results
Susceptible to
Meropenem (MIC 0.04)
Ertapenem (MIC 0.25 mg/L)
Resistant to
Cefta avi
ATM
3GC
Intermediate to
Cefiderocol
What are the R mechanisms?
@MicroLukas
@dralicehan
@wfwrighID
@davidvanduin
@OncIDPharmd
10
4
28
Generic Ceftazidime-avibactam will be launched soon in India
More than 10 companies will introduce the generic versions there
Judicious use is needed to avoid catastrophe. And there's no recommendation (CLSI or EUCAST) on synergy testing for CZA and ATM at the moment
Ceftazidime avibactam has lost its exclusivity and is now a generic drug in India. To prevent its indiscriminate use, the medical community must be educated for its judicious use.
@CidsIndia
@vbalaji7
@icmr
#AMR
#antimicrobialstewardship
4
30
88
2
7
28
Attended this great talk yesterday by
@annapralph
during the
@CRE_RESPOND
Respiratory Infections: Pneumonia Seminar!
Melioidosis is common in Darwin, Aus. She shared with us 2 papers published recently on this
Paper 1
Paper 2
1
7
26
The GAME CHANGER trial presented by
@davidantibiotic
at
#ESCMIDGlobal2024
👏👏
The trial stands for Investigator-driven randomized controlled trial of cefiderocol versus SoC for HCA and HA GNB BSI
@padstamundo
@UQ_GAMECHANGER
1
3
28
This is the spectrum of activity of the new BLBLIs
And of these, only Sulbactam/durlobactam has activity against CRAB
Durlobactam is the next gen-DBO with an extended activity against the class D enzymes - which are the primary R mechanisms by Acinetobacter baumannii
1
9
27
Let's nudge each others into reducing inappropriate antibiotics in pneumonia. HOW? Simply by indicating no MRSA and no Pseudomonas were found in respi report, influenced clinicians into reducing abx use. …
@ABXPharmD
@ABsteward
@ASPphysician
@NCAS_Aus
2
10
25
Part 1: How to approach and treat AmpC and ESBL infections?
By
@febrilepodcast
@pranita_tamma
Let's listen to this
@SyamhaninA
@adammashraff
@fikreeahmad
@SazaliBasri
@HanzHc
@PuiLi_Wong
@ummuafeera
@alif82
@shaharudeen
@GSRajahram
#IDTwitter
0
8
25
Risk factors for persistent bacteremia in patients with GNB BSI: an SR with meta-analysis
Do you do a FUBC in GNB patients?
@alif82
(something that might interest you)
QnA: How freq was the FUBC in these studies?
Variable ways of FUBC in all the included studies
#ECCMID2023
3
13
23
Do you use Cefadroxil for MSSA infection?
Do you know that it is available locally?
It offers less frequent dosing due to its longer half-life vs. cephalexin
A trendy oral step-down choice!
@DrSyamhanin
@adammashraff
@shaharudeen
@Rasidah
@SazaliBasri
3
5
25
Interesting questions at
#ESCMIDGlobal2024
on PJP in ICU patients
Is the use of echinocandins be driving the low rates of PJP in ICU patients?
Can we use low dose of TMP-SMX for the treatment for PJP?
What is the optimal steroid dose in PJP in non-HIV patients?
2
2
25
Before SIMPLIFY, evidence for de-escalating anti-pseudomonal antibiotics in Enterobacterales bacteremia was weak
#AMS
#SIMPLIFY
Visit our 'revived' MAMSIG website to learn more
@DrSyamhanin
@fikreeahmad
@adammashraff
@IcidMy
@shaharudeen
@GSRajahram
1
9
24
A new paper on RDT implementation coupled with AMS interventions in a US hospital for CRE and PA infections
@ADVANCE__ID
Thank you
@ABsteward
for highlighting the paper
#IDtwitter
1
5
24
Does AMR increase the risk for bacteremia recurrence?
Session: Impact of antimicrobial resistance on the risk of recurrence after community-onset bacteremia
Speaker: Salam Abarra
#ECCMID2023
1
6
24
The launch of
#ADVANCEID
by
@davidantibiotic
at NUS
He also gave his takes on 10 most pressing questions in ID research that we should pursue
Looking forward to be part of this research network
@HanzHc
@GSRajahram
1
3
23
How do you use CZA + ATM in CRE isolates resistant to CZA and ATM?
A) Use it right away
B) Do a synergy test
If you choose B, which test would you use:
1) Disc
2) E-test
3) BDE method
@alif82
@PuiLi_Wong
@SazaliBasri
@SyamhaninA
@adammashraff
6
7
22
A new scoping review of risk-scoring tools to predict CRE BSI early by
@AbdullahTarikA1
@davidantibiotic
et al.
Congrats Tarik on this new paper- let’s read the paper
@SazaliBasri
@HanzHc
@PuiLi_Wong
@Rasidah
@GSRajahram
@stevenlimcl
@DrSyamhanin
2
6
22
Interesting case discussion on pulmonary KS
#ESCMIDGlobal2024
Interestingly, Toci was used in this case, and that he had scurvy, with was detected only later (low serum vit C level)
@alif82
@Rasidah
@dr_aishah_wahid
@SazaliBasri
@HanzHc
2
1
20
Exciting findings following the largest-ever deployment of Wolbachia-infected mosquitoes
In neighbourhoods of Colombia where the Wolbachia mosquitoes were well established, dengue incidence dropped by 94–97%
@GSRajahram
@stevenlimcl
@RoshwiniM
Dengue rates drop after release of modified mosquitoes in Colombia
2
19
40
2
8
21
How dangerous is pip-tazo + vancomycin combo to the kidneys?
Check this highlight on a paper by
@IDPharmacometrx
et al
BTW nothing beats reading the paper in full.
@cllau888
@KNRXRX
@nicolencz
@limhh7
@GSRajahram
@SyamhaninA
@suraya
1
2
21
The AM8 was a success this year!
Shout out to
@BradSpellberg
for sharing his expertise via the "Shorter is better" lecture today
Thanks to other speakers too
Hope U guys enjoyed the lectures & the QnA sessions
See you all next year!!!
@cllau888
@shaharudeen
@ProfAdeeba
2
2
21
Nearly every minute, a child under 5 dies of malaria. Many of these deaths are preventable and treatable…
A lecture by
@GSRajahram
titled “Malarias in South East Asia and Beyond” at UM/Glasgow
#TropMedGlobalVoyage
1
2
21
When not to start antibiotics: avoiding antibiotic overuse in the intensive care unit?
By
@padstamundo
and team.
Full paper:
@SyamhaninA
@GSRajahram
@1103Chrysalis
@andrewchang_ID
@suraya_sudenia
2
11
21
Congrats to the members of our ID unit and the nephrology and urology teams involved in the first kidney transplant in a PLWHIV in Malaysia
Together, we can achieve more and go much further
0
1
19
Shameless self-promotion on our paper;
Clinical prediction models for ESBL-Enterobacteriaceae colonization or infection: An SR
Published at J of Hosp Infection;
@jhieditor
@ABsteward
@khalideljaaly
@saveantibiotics
#ESBL
#AntibioticResistance
2
10
19
How long should we "prophylax" patient who is undergoing cardiac surgery with antibiotics?
A) 24 hours
B) 48 hours
C) 72 hour
D) A week
The answer:
@ABsteward
@khalideljaaly
@nicolencz
@suraya_sudenia
2
24
20
Are you the superhero of Carbapenem-resistant GNB infection? If that's a big YES, we need your superpowers for this survey!
Don't keep it to yourself – share the love with your colleagues too! 🤝🦸♀️🦸♂️
#SuperbugBusters
A research by
@ADVANCE__ID
1
12
19